WallStreetZenWallStreetZen

NASDAQ: SLS
Sellas Life Sciences Group Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Sellas Life Sciences Group earnings were -$27.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SLS earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$5.8M, down 13.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SLS reported annual earnings of -$30.9M, with -17.3% growth.

SLS earnings history

Current Revenue
$0.0
Current Earnings
-$27.1M
Current Profit Margin
0%

SLS Return on Equity

Current Company
-193.7%
Current Industry
-60.2%
Current Market
31.5%
SLS's Return on Equity (-193.7%)... subscribe to Premium to read more.
High Return on Equity Performance

SLS undefined

Current Company
-113%
Current Industry
-2.5%
SLS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SLS announces earnings.

SLS undefined

Current Company
-96.65%
Current Industry
5.8%
SLS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SLS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SLS-$26.56M-$27.13MN/A-$0.38
PBYI$54.66M$38.07M+177.49%$0.77
EDIT-$254.44M-$251.23MN/A-$3.04
ALDX-$55.54M-$57.70MN/A-$0.97
CYBN-$71.77M-$72.16MN/A-$3.41
View Top Biotech Stocks

Sellas Life Sciences Group Earnings Reports & History FAQ

What were Sellas Life Sciences Group's earnings last quarter?

On SLS's earnings call on Invalid Date, Sellas Life Sciences Group (NASDAQ: SLS) reported Q1 2025 earnings per share (EPS) of -$0.07, up 66.67% year over year. Total SLS earnings for the quarter were -$5.81 million. In the same quarter last year, Sellas Life Sciences Group's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Sellas Life Sciences Group stock.

Is Sellas Life Sciences Group profitable or losing money?

As of the last Sellas Life Sciences Group earnings report, Sellas Life Sciences Group is currently losing money. Sellas Life Sciences Group's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$27.13 million, a 24.24% decrease year over year.

What was SLS's earnings growth in the past year?

As of Sellas Life Sciences Group's earnings date in Invalid Date, Sellas Life Sciences Group's earnings has grown year over year. SLS earnings in the past year totalled -$27.13 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.